Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Protagonist Therapeutics, Inc.

SG&A Expenses: Walgreens vs. Protagonist, 2014-2023

__timestampProtagonist Therapeutics, Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 2014186000017992000000
Thursday, January 1, 2015296300022400000000
Friday, January 1, 2016696100023910000000
Sunday, January 1, 20171177900023813000000
Monday, January 1, 20181369700024694000000
Tuesday, January 1, 20191574900023557000000
Wednesday, January 1, 20201863800025436000000
Friday, January 1, 20212719600024586000000
Saturday, January 1, 20223173900027295000000
Sunday, January 1, 20233349100034205000000
Monday, January 1, 202428113000000
Loading chart...

Unlocking the unknown

A Tale of Two Companies: SG&A Expenses Over Time

In the world of corporate finance, Selling, General, and Administrative (SG&A) expenses are a crucial indicator of a company's operational efficiency. This chart compares the SG&A expenses of Walgreens Boots Alliance, Inc. and Protagonist Therapeutics, Inc. from 2014 to 2023. Walgreens, a retail giant, consistently shows SG&A expenses in the range of $17.7 billion to $28.1 billion, reflecting its expansive global operations. In contrast, Protagonist Therapeutics, a smaller biotech firm, has seen its SG&A expenses grow from $1.9 million to $33.5 million, indicating a significant expansion phase.

Interestingly, Walgreens' expenses have remained relatively stable, with a slight upward trend, while Protagonist's expenses have surged by over 1,700% in the same period. This divergence highlights the different growth trajectories and operational scales of these two companies. Notably, data for 2024 is missing for Protagonist, suggesting a need for further updates.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025